CRNX
CRNX
NASDAQ · Pharmaceuticals

Crinetics Pharmaceuticals In

$84.08
+0.16 (+0.19%)
As of Aug 7, 8:30 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target -41.2% upside
Low Target $38.77
Average Target $49.40
High Target $74.88
Current Price $84.08
Current
$84.08
Target
$49.40
$38.77 $49.40 avg $74.88
Scenario Analysis
Bear Case
$38.77
-53.9%
Low target
Base Case
$49.40
-41.2%
Avg target
Bull Case
$74.88
+-10.9%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$84.00
0.1% from high
52-Week Low
$25.83
+225.5% from low
50-Day SMA
$49.40
+70.2% vs SMA
200-Day SMA
$38.81
+116.6% vs SMA
RSI (14)
27.9
Oversold
Target vs 52W High
$49.40
-41.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.7%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +189.0%